Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira T Lott

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 8, 2020
Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndromeMark Mapstone, Thomas J Gross, Fabio Macciardi, et al.
Brain Sciences|July 27, 2022
Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer's Disease in Down Syndrome: Comparing Models. <i>Brain</i><i>Sci.</i> 2021, <i>11</i>, 1220Christy L Hom, Katharine A Kirby, Joni Ricks-Oddie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2025
Neuropsychiatric symptoms and emerging dementia in people with Down syndrome and older adultsChristina M Magana-Ramirez, Daniel L Gillen, Christy L Hom, et al.
Brain Sciences|September 28, 2021
Cognitive Function during the Prodromal Stage of Alzheimer's Disease in Down Syndrome: Comparing ModelsChristy L Hom, Katharine A Kirby, Joni Ricks-Oddie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsChristina M Magana-Ramirez, Daniel L Gillen, Christy L Hom, et al.
Journal of Alzheimer'S Disease : JAD|November 15, 2021
Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down SyndromeNatalie D DiProspero, David B Keator, Michael Phelan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 17, 2020
Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndromeRachel L Henson, Eric Doran, Bradley T Christian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLisa M Taylor, Jenna N Adams, Natalie DiProspero, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 18, 2020
Brain amyloid and the transition to dementia in Down syndromeDavid B Keator, Eric Doran, Lisa Taylor, et al.
JAMA Neurology|August 19, 2024
Lecanemab and Vascular-Amyloid Deposition in Brains of People With Down SyndromeLei Liu, Adriana Saba, Jesse R Pascual, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 8, 2020
Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndromeMark Mapstone, Thomas J Gross, Fabio Macciardi, et al.
Brain Sciences|July 27, 2022
Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer's Disease in Down Syndrome: Comparing Models. <i>Brain</i><i>Sci.</i> 2021, <i>11</i>, 1220Christy L Hom, Katharine A Kirby, Joni Ricks-Oddie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2025
Neuropsychiatric symptoms and emerging dementia in people with Down syndrome and older adultsChristina M Magana-Ramirez, Daniel L Gillen, Christy L Hom, et al.
Brain Sciences|September 28, 2021
Cognitive Function during the Prodromal Stage of Alzheimer's Disease in Down Syndrome: Comparing ModelsChristy L Hom, Katharine A Kirby, Joni Ricks-Oddie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsChristina M Magana-Ramirez, Daniel L Gillen, Christy L Hom, et al.
Journal of Alzheimer'S Disease : JAD|November 15, 2021
Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down SyndromeNatalie D DiProspero, David B Keator, Michael Phelan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 17, 2020
Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndromeRachel L Henson, Eric Doran, Bradley T Christian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLisa M Taylor, Jenna N Adams, Natalie DiProspero, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 18, 2020
Brain amyloid and the transition to dementia in Down syndromeDavid B Keator, Eric Doran, Lisa Taylor, et al.
JAMA Neurology|August 19, 2024
Lecanemab and Vascular-Amyloid Deposition in Brains of People With Down SyndromeLei Liu, Adriana Saba, Jesse R Pascual, et al.
Pageof 9